Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study

BACKGROUND: Long-term use of inhaled corticosteroids (ICSs) has been associated with increased risk of bone and ocular comorbidities. We evaluated the effects of the triple fixed-dose combination budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI), formulated using co-suspen...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Respir Res
Päätekijät: Kerwin, Edward M., Ferguson, Gary T., Mo, Mindy, DeAngelis, Kiernan, Dorinsky, Paul
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6664772/
https://ncbi.nlm.nih.gov/pubmed/31358008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1126-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia